Iceland· IS-IS/1/03/003/01
Ezetrol
A ezetimibe product containing ezetimibe, registered in Iceland by N.V. Organon*. The same ATC class is registered in 17 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Ezetimibe is registered in 17 of 19 countries.
Countries holding a registration under ATC C10AX09 (ezetimibe), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Ezetimibe · ATC C10AX09
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ezetimibe costs, country by country.
Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.067 in United States to $1.32 in Switzerland — a ×20 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Ezetimibe · price per daily dose (10 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.32
- IT Italy$0.80
- FR France$0.45
- US United States$0.067 (acquisition cost)
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Ezetimibe
- Manufacturer
- N.V. Organon*
- Country
- Iceland (IS)
- ATC code
- C10AX09
- ATC class
- Ezetimibe
- Defined daily dose
- 10 mg, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 2
2 priced- ean47701798 stk x1 þpakkiISK 21736
- ean40057328 stk x1 þpakkiISK 8110
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
236 interactions on record for ezetimibe.
Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ezetimibe · interactions on record
236 records
- 23 moderate
- 2 minor
- 210 info
Most severe, free to view
- Chenodeoxycholic acidA05AA01moderate
- EluxadolineA07DA06moderate
- EltrombopagB02BX05moderate
- SimvastatinC10AA01moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C10AX09
Ezetimibe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eff82e76-1f2b-479e-abd3-b5b6a30cf31f GET /v1/drugs/eff82e76-1f2b-479e-abd3-b5b6a30cf31f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tafla",
"source": "lyfjastofnun",
"atc_raw": "C10AX09",
"marketed": true,
"strength": "10 mg",
"ma_number": "IS/1/03/003/01",
"substance": "Ezetimibe",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "37699"
}See everything about ezetimibe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.